I still don't understand stocks, tbf.View Entire Post ›...
Budget alternatives to splurge-worthy makeup, a cleanser that'll change your life, and the *cutest* nail designs — all just an "add to cart" away.View Entire Post ›...
Multiple people are feared to be trapped following a home explosion in New Jersey on Friday night...
I know the eye contact in that house is unsettling as hell."View Entire Post ›...
A saltwater intrusion in the water supply that's pumped out of the Mississippi river is threatening the drinking water of nearly 900,000 residents, who now must rethink everyday activities...
At Microsoft’s fall event today, the company’s signature tablets appear to be a no-show. But that doesn’t mean there’s no new hardware to show off. Both the low-price Surface Laptop Go and the high-end Surface Laptop Studio are getting refreshed with new chips, the latest Windows 11 AI-focused features...
Microsoft has apparently decided to make the Surface Go line of tiny tablets a purely business device, announcing the Surface Go 4 for Business but without a consumer option. What’s new? The lack of Arm options and a new Intel processor. Intel Microsoft didn’t reveal a starting price for the Surface Go 4 for Business...
Woodley's push...
From a castle-like resort in Quebec City to a hot springs retreat in the Arizona desert, these stays come with colorful scenery and stories.
Berlin, Germany, San Diego, CA, USA, September 18, 2023 – Vividion Therapeutics, Inc. (Vividion), announced today that it has initiated dosing of patients in a Phase I oncology clinical trial of its investigational oral Kelch-like ECH Associated Protein 1 (KEAP1) activator, VVD-130037. Vividion is a biopharmaceutical company utilizing novel discovery technologies to unlock high value...
- Advertisement -
